Crinetics Pharmaceuticals Inc (CRNX)
53.14
+0.37
(+0.70%)
USD |
NASDAQ |
Oct 04, 16:00
53.99
+0.85
(+1.60%)
Pre-Market: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Annual): 539.11M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 539.11M |
| December 31, 2022 | 316.33M |
| December 31, 2021 | 331.94M |
| December 31, 2020 | 168.92M |
| Date | Value |
|---|---|
| December 31, 2019 | 117.14M |
| December 31, 2018 | 160.22M |
| December 31, 2017 | -15.02M |
| December 31, 2016 | -6.204M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
117.14M
Minimum
2019
539.11M
Maximum
2023
294.69M
Average
316.33M
Median
2022
Shareholders Equity (Annual) Benchmarks
| PTC Therapeutics Inc | -818.56M |
| Zevra Therapeutics Inc | 61.86M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |